These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Therapeutic gene transfer for rheumatoid arthritis. Boissier MC; Bessis N Reumatismo; 2004; 56(1 Suppl 1):51-61. PubMed ID: 15201941 [TBL] [Abstract][Full Text] [Related]
3. Ex vivo gene delivery of IL-1Ra and soluble TNF receptor confers a distal synergistic therapeutic effect in antigen-induced arthritis. Kim SH; Lechman ER; Kim S; Nash J; Oligino TJ; Robbins PD Mol Ther; 2002 Nov; 6(5):591-600. PubMed ID: 12409257 [TBL] [Abstract][Full Text] [Related]
4. Adenoviral delivery of IL-1 receptor antagonist abrogates disease activity during the development of autoimmune arthritis in IL-1 receptor antagonist-deficient mice. Hur W; Cho ML; Yoon SK; Kim SY; Ju JH; Jhun JY; Heo SB; Moon YM; Min SY; Park SH; Kim HY Immunol Lett; 2006 Aug; 106(2):154-62. PubMed ID: 16793145 [TBL] [Abstract][Full Text] [Related]
12. Recent developments in molecular therapeutic approaches for rheumatoid arthritis. Woods A; Hobson P; Klavinskis LS Curr Opin Mol Ther; 2004 Aug; 6(4):395-402. PubMed ID: 15468598 [TBL] [Abstract][Full Text] [Related]
13. Enhanced gene transfer to arthritic joints using adeno-associated virus type 5: implications for intra-articular gene therapy. Adriaansen J; Tas SW; Klarenbeek PL; Bakker AC; Apparailly F; Firestein GS; Jorgensen C; Vervoordeldonk MJ; Tak PP Ann Rheum Dis; 2005 Dec; 64(12):1677-84. PubMed ID: 15878906 [TBL] [Abstract][Full Text] [Related]
14. Suppression of experimental osteoarthritis by adenovirus-mediated double gene transfer. Wang HJ; Yu CL; Kishi H; Motoki K; Mao ZB; Muraguchi A Chin Med J (Engl); 2006 Aug; 119(16):1365-73. PubMed ID: 16934183 [TBL] [Abstract][Full Text] [Related]
15. Gene therapy of autoimmune diseases with vectors encoding regulatory cytokines or inflammatory cytokine inhibitors. Prud'homme GJ J Gene Med; 2000; 2(4):222-32. PubMed ID: 10953913 [TBL] [Abstract][Full Text] [Related]
16. In vivo delivery of lentiviral vectors expressing vasoactive intestinal peptide complementary DNA as gene therapy for collagen-induced arthritis. Delgado M; Toscano MG; Benabdellah K; Cobo M; O'Valle F; Gonzalez-Rey E; Martín F Arthritis Rheum; 2008 Apr; 58(4):1026-37. PubMed ID: 18383372 [TBL] [Abstract][Full Text] [Related]
17. Suppression of arthritic bone destruction by adenovirus-mediated dominant-negative Ras gene transfer to synoviocytes and osteoclasts. Yamamoto A; Fukuda A; Seto H; Miyazaki T; Kadono Y; Sawada Y; Nakamura I; Katagiri H; Asano T; Tanaka Y; Oda H; Nakamura K; Tanaka S Arthritis Rheum; 2003 Sep; 48(9):2682-92. PubMed ID: 13130489 [TBL] [Abstract][Full Text] [Related]
18. Local delivery of a recombinant adenoassociated vector containing a tumour necrosis factor alpha antagonist gene in inflammatory arthritis: a phase 1 dose-escalation safety and tolerability study. Mease PJ; Hobbs K; Chalmers A; El-Gabalawy H; Bookman A; Keystone E; Furst DE; Anklesaria P; Heald AE Ann Rheum Dis; 2009 Aug; 68(8):1247-54. PubMed ID: 18678578 [TBL] [Abstract][Full Text] [Related]
19. [Gene therapy in rheumatoid arthritis: new aspects]. Pundt N; Peters MA; Wunrau C; Pap T Dtsch Med Wochenschr; 2008 Aug; 133(34-35):1737-41. PubMed ID: 18696407 [TBL] [Abstract][Full Text] [Related]
20. Single and combined inhibition of tumor necrosis factor, interleukin-1, and RANKL pathways in tumor necrosis factor-induced arthritis: effects on synovial inflammation, bone erosion, and cartilage destruction. Zwerina J; Hayer S; Tohidast-Akrad M; Bergmeister H; Redlich K; Feige U; Dunstan C; Kollias G; Steiner G; Smolen J; Schett G Arthritis Rheum; 2004 Jan; 50(1):277-90. PubMed ID: 14730626 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]